Metrics to compare | EESP | Peers Peers - average of corresponding metrics from companies closely matching EESP: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEESPPeersSector |
|---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | −0.3x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 2.6x | |
Price / LTM Sales | 0.0x | 0.0x | 3.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 53.8% | |
Fair Value Upside | Unlock | 0.0% | 8.6% | Unlock |
Euroespes, S.A., a medical center, provides medical services for the research, diagnosis, and treatment of central nervous system in Spain and internationally. The company offers personalized and genomic medicine services for predictive and diagnostic genetics, and pharmacogenetics. It also provides medical services, such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, digital diagnostics, radiodiagnosis, nursing, and cardiology. In addition, the company offers genomics, epigenetics, and pharmacogenomics services and products, as well as is involved in the Production, distribution and sale of nutraceutical bioproducts. Euroespes, S.A. was incorporated in 1991 and is headquartered in Corunna, Spain.